NO161679C - Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. - Google Patents

Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.

Info

Publication number
NO161679C
NO161679C NO843406A NO843406A NO161679C NO 161679 C NO161679 C NO 161679C NO 843406 A NO843406 A NO 843406A NO 843406 A NO843406 A NO 843406A NO 161679 C NO161679 C NO 161679C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
active steroids
analogy procedure
analogy
Prior art date
Application number
NO843406A
Other languages
English (en)
Norwegian (no)
Other versions
NO843406L (no
NO161679B (no
Inventor
Jean-Marie Cassal
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO843406L publication Critical patent/NO843406L/no
Publication of NO161679B publication Critical patent/NO161679B/no
Publication of NO161679C publication Critical patent/NO161679C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843406A 1983-08-25 1984-08-24 Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider. NO161679C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH464483 1983-08-25

Publications (3)

Publication Number Publication Date
NO843406L NO843406L (no) 1985-02-26
NO161679B NO161679B (no) 1989-06-05
NO161679C true NO161679C (no) 1989-09-13

Family

ID=4279973

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843406A NO161679C (no) 1983-08-25 1984-08-24 Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.

Country Status (21)

Country Link
US (1) US4680290A (fr)
EP (1) EP0135762B1 (fr)
JP (1) JPS6061595A (fr)
KR (1) KR850001767A (fr)
AR (1) AR240834A1 (fr)
AT (1) ATE37883T1 (fr)
AU (1) AU574706B2 (fr)
CA (1) CA1252778A (fr)
DE (1) DE3474552D1 (fr)
DK (1) DK347584A (fr)
ES (2) ES8602844A1 (fr)
FI (1) FI842830A (fr)
GR (1) GR80196B (fr)
HU (1) HU189929B (fr)
IL (1) IL72725A (fr)
MC (1) MC1618A1 (fr)
NO (1) NO161679C (fr)
NZ (1) NZ209275A (fr)
PH (1) PH19849A (fr)
PT (1) PT79130B (fr)
ZA (1) ZA846430B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1241947A (fr) * 1985-05-31 1988-09-13 Pierre R. Proulx Derives de sterol-polyene pour sondes de membranes
US4946834A (en) * 1988-12-23 1990-08-07 Smithkline Beecham Corporation Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors
US5026882A (en) * 1988-12-23 1991-06-25 Smithkline Beecham Corporation Phosphinic acid substituted steroids as inhibitors of steroid 5α-reductase
US5215972A (en) * 1989-11-22 1993-06-01 Hoffmann-La Roche Inc. Steroids
CA2028759A1 (fr) * 1989-11-22 1991-05-23 Jean-Marie Cassal Steroides
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
EP0796112A4 (fr) * 1994-11-30 1999-12-01 Amur Research Corp Derives medicamenteux de la phosphocholine
US6251939B1 (en) 1995-06-07 2001-06-26 Promega Biosciences, Inc. Carbamate-based cationic lipids
JPH11507815A (ja) * 1995-06-07 1999-07-13 ジンタ・インコーポレイテッド ホスホン酸基本カチオン性脂質
CA2266404A1 (fr) * 1996-09-17 1998-03-26 Amur Pharmaceuticals, Inc. Derives de medicaments phospholipidiques
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
CA2330611A1 (fr) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Molecules bifonctionnelles et therapies basees sur celles-ci
CA2395447A1 (fr) 2000-01-28 2001-08-02 Robert Joseph Sarama Composes d'arginine d'un gout agreable et leurs utilisations pour la sante cardio-vasculaire
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
EP1945240B1 (fr) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
EP2097081A1 (fr) * 2006-12-08 2009-09-09 Jado Technologies GmbH Cholestérylamines pour le traitement et la prévention de maladies infectieuses
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2023122075A1 (fr) * 2021-12-20 2023-06-29 Ohio State Innovation Foundation Compositions comprenant des composés de stérol-amino-phosphate et leurs procédés de fabrication et d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3248408A (en) * 1963-07-22 1966-04-26 Merck & Co Inc Purification of steroid phosphates

Also Published As

Publication number Publication date
HU189929B (en) 1986-08-28
NO843406L (no) 1985-02-26
IL72725A0 (en) 1984-11-30
HUT34997A (en) 1985-05-28
FI842830A (fi) 1985-02-26
PH19849A (en) 1986-07-22
AR240834A1 (es) 1991-02-28
GR80196B (en) 1985-01-02
CA1252778A (fr) 1989-04-18
NZ209275A (en) 1987-06-30
ES543646A0 (es) 1986-05-01
JPS6061595A (ja) 1985-04-09
AR240834A2 (es) 1991-02-28
NO161679B (no) 1989-06-05
ES8606879A1 (es) 1986-05-01
EP0135762A3 (en) 1986-01-22
AU574706B2 (en) 1988-07-14
ZA846430B (en) 1985-04-24
DE3474552D1 (en) 1988-11-17
KR850001767A (ko) 1985-04-01
EP0135762A2 (fr) 1985-04-03
PT79130B (en) 1986-11-14
AU3222584A (en) 1985-02-28
US4680290A (en) 1987-07-14
EP0135762B1 (fr) 1988-10-12
ES535391A0 (es) 1985-12-01
DK347584D0 (da) 1984-07-13
DK347584A (da) 1985-02-26
ES8602844A1 (es) 1985-12-01
FI842830A0 (fi) 1984-07-13
PT79130A (en) 1984-09-01
IL72725A (en) 1988-07-31
ATE37883T1 (de) 1988-10-15
MC1618A1 (fr) 1985-07-18

Similar Documents

Publication Publication Date Title
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162858C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater.
NO156525C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (3-aminopropoksy)bibenzylderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO163693C (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser av platina.
NO167510C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenylkinolincarboxylsyrer
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO159528C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aminoguanidinderivater.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO831588L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-4-piperidincarbinoler
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.